Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Evelo Biosciences stock
Own Evelo Biosciences stock in just a few minutes.
Evelo Biosciences, Inc is a biotechnology business based in the US. Evelo Biosciences shares (EVLO) are listed on the NASDAQ and all prices are listed in US Dollars. Evelo Biosciences employs 90 staff and has a market cap (total outstanding shares value) of USD$534.9 million.
How to buy shares in Evelo Biosciences
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Evelo Biosciences. Find the stock by name or ticker symbol: EVLO. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Evelo Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Evelo Biosciences, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Evelo Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Evelo Biosciences share price
Use our graph to track the performance of EVLO stocks over time.Evelo Biosciences shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$3.55 - USD$19.928 |
|---|---|
| 50-day moving average | USD$12.1294 |
| 200-day moving average | USD$9.6183 |
| Wall St. target price | USD$20.2 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-2.27 |
Buy Evelo Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Evelo Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evelo Biosciences financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | -63.26% |
| Return on equity TTM | -206.58% |
| Profit margin | 0% |
| Book value | $0.642 |
| Market capitalisation | USD$534.9 million |
TTM: trailing 12 months
Shorting Evelo Biosciences shares
There are currently 2.9 million Evelo Biosciences shares held short by investors – that's known as Evelo Biosciences's "short interest". This figure is 25.7% up from 2.3 million last month.
There are a few different ways that this level of interest in shorting Evelo Biosciences shares can be evaluated.
Evelo Biosciences's "short interest ratio" (SIR)
Evelo Biosciences's "short interest ratio" (SIR) is the quantity of Evelo Biosciences shares currently shorted divided by the average quantity of Evelo Biosciences shares traded daily (recently around 233612.88782816). Evelo Biosciences's SIR currently stands at 12.57. In other words for every 100,000 Evelo Biosciences shares traded daily on the market, roughly 12570 shares are currently held short.
However Evelo Biosciences's short interest can also be evaluated against the total number of Evelo Biosciences shares, or, against the total number of tradable Evelo Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Evelo Biosciences's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Evelo Biosciences shares in existence, roughly 60 shares are currently held short) or 0.0928% of the tradable shares (for every 100,000 tradable Evelo Biosciences shares, roughly 93 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Evelo Biosciences.
Find out more about how you can short Evelo Biosciences stock.
Evelo Biosciences share dividends
We're not expecting Evelo Biosciences to pay a dividend over the next 12 months.
Evelo Biosciences share price volatility
Over the last 12 months, Evelo Biosciences's shares have ranged in value from as little as $3.55 up to $19.928. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evelo Biosciences's is 1.2498. This would suggest that Evelo Biosciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Evelo Biosciences overview
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert